Corruption law's importance to Triangle companies
In the international business community, few law enforcement matters in recent years have attracted as much attention as the Foreign Corrupt Practices Act. FCPA enforcement - conducted by both the U.S. Department of Justice and the Securities and Exchange Commission - has been intense and increasing over the last decade. The total numbers of FCPA actions brought by both agencies have risen from a mere five in 2004 to between 40 and 74 in the last three years. This trend has particular relevance for Triangle companies, including pharmaceutical companies and clinical-research organizations.
To read the full article by Brooks Pierce attorney and former SEC staffer David Smyth, see attached document.